Topical application of <em>Porphyromonas gingivalis</em> into the gingival pocket in mice leads to chronic‑active infection, periodontitis and systemic inflammation

Kim,Sharon; Kim,Sharon; Bando,Yasuhiko; Bando,Yasuhiko; Chang,Chungyu; Chang,Chungyu; Kwon,Jeonga; Kwon,Jeonga; Tarverti,Berta; Tarverti,Berta; Kim,Doohyun; Kim,Doohyun; Lee,Sung Hee; Lee,Sung Hee; Ton-That,Hung; Ton-That,Hung; Kim,Reuben; Kim,Reuben; Nara,Peter L.; Nara,Peter L.; Park,No-Hee; Park,No-Hee

doi:10.3892/ijmm.2022.5159

Topical application of Porphyromonas gingivalis into the gingival pocket in mice leads to chronic‑active infection, periodontitis and systemic inflammation

Authors:
- Sharon Kim
- Yasuhiko Bando
- Chungyu Chang
- Jeonga Kwon
- Berta Tarverti
- Doohyun Kim
- Sung Hee Lee
- Hung Ton-That
- Reuben Kim
- Peter L. Nara
- No-Hee Park
View Affiliations

Affiliations: The Shapiro Family Laboratory of Viral Oncology and Aging Research, UCLA School of Dentistry, Los Angeles, CA 90095, USA, Section of Oral Biology, UCLA School of Dentistry, Los Angeles, CA 90095, USA, Keystone Bio Incorporated, Suite 200, St. Louis, MO 63110, USA
Published online on: June 15, 2022 https://doi.org/10.3892/ijmm.2022.5159
Article Number: 103
Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Porphyromonas gingivalis (Pg), one of the ‘red‑complex’ perio‑pathogens known to play a critical role in the development of periodontitis, has been used in various animal models to mimic human bacteria‑induced periodontitis. In order to achieve a more realistic animal model of human Pg infection, the present study investigated whether repeated small‑volume topical applications of Pg directly into the gingival pocket can induce local infection, including periodontitis and systemic vascular inflammation in wild‑type mice. Freshly cultured Pg was topically applied directly into the gingival pocket of the second molars for 5 weeks (3 times/week). After the final application, the mice were left in cages for 4 or 8 weeks and sacrificed. The status of Pg colony formation in the pocket, gingival inflammation, alveolar bone loss, the expression levels of pro‑inflammatory cytokines in the serum and aorta, the presence of anti‑Pg lipopolysaccharide (LPS) and gingipain (Kpg and RgpB) antibodies in the serum, as well as the accumulation of Pg LPS and gingipain aggregates in the gingiva and arterial wall were evaluated. The topical application of Pg into the gingival pocket induced the following local and systemic pathohistological changes in mice when examined at 4 or 8 weeks after the final topical Pg application: Pg colonization in the majority of gingival pockets; increased gingival pocket depths; gingival inflammation indicated by the increased expression of TNF‑α, IL‑6 and IL‑1β; significant loss of alveolar bone at the sites of topical Pg application; and increased levels of pro‑inflammatory cytokines, such as TNF‑α, IL‑1β, IL‑17, IL‑13, KC and IFN‑γ in the serum in comparison to those from mice receiving PBS. In addition, the Pg application/colonization model induced anti‑Pg LPS and gingipain antibodies in serum, as well as the accumulation of Pg LPS and gingipain aggregates in the gingivae and arterial walls. To the best of our knowledge, this mouse model represents the first example of creating a more sustained local infection in the gingival tissues of wild‑type mice and may prove to be useful for the investigation of the more natural and complete pathogenesis of the bacteria in the development of local oral and systemic diseases, such as atherosclerosis. It may also be useful for the determination of a treatment/prevention/efficacy model associated with Pg‑induced colonization periodontitis in mice.

View Figures

View References

1	Darveau RP: Periodontitis: A polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 8:481–490. 2010. View Article : Google Scholar : PubMed/NCBI
2	Hajishengallis G, Wang M and Liang S: Induction of distinct TLR2-mediated proinflammatory and proadhesive signaling pathways in response to porphyromonas gingivalis fimbriae. J Immunol. 182:6690–6696. 2009. View Article : Google Scholar : PubMed/NCBI
3	Takii R, Kadowaki T, Baba A, Tsukuba T and Yamamoto K: A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems. Infect Immun. 73:883–893. 2005. View Article : Google Scholar : PubMed/NCBI
4	Hiyari S, Atti E, Camargo PM, Eskin E, Lusis AJ, Tetradis S and Pirih FQ: Heritability of periodontal bone loss in mice. J Periodontal Res. 50:730–736. 2015. View Article : Google Scholar : PubMed/NCBI
5	Liu R, Desta T, Raptis M, Darveau RP and Graves DT: P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers. J Periodontol. 79:1241–1247. 2008. View Article : Google Scholar : PubMed/NCBI
6	Suh JS, Kim S, Boström KI, Wang CY, Kim RH and Park NH: Periodontitis-induced systemic inflammation exacerbates atherosclerosis partly via endothelial-mesenchymal transition in mice. Int J Oral Sci. 11:212019. View Article : Google Scholar : PubMed/NCBI
7	Imamura T: The role of gingipains in the pathogenesis of periodontal disease. J Periodontol. 74:111–118. 2003. View Article : Google Scholar : PubMed/NCBI
8	O'Brien-Simpson NM, Paolini RA, Hoffmann B, Slakeski N, Dashper SG and Reynolds EC: Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model. Infect Immun. 69:7527–7534. 2001. View Article : Google Scholar : PubMed/NCBI
9	Pike RN, Potempa J, McGraw W, Coetzer TH and Travis J: Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J Bacteriol. 178:2876–2882. 1996. View Article : Google Scholar : PubMed/NCBI
10	Ding PH, Yang MX, Wang NN, Jin LJ, Dong Y, Cai X and Chen LL: Porphyromonas gingivalis-induced NLRP3 inflammasome activation and its downstream interleukin-1beta release depend on caspase-4. Front Microbiol. 11:18812020. View Article : Google Scholar
11	Fitzpatrick RE, Wijeyewickrema LC and Pike RN: The gingipains: Scissors and glue of the periodontal pathogen, Porphyromonas gingivalis. Future Microbiol. 4:471–487. 2009. View Article : Google Scholar : PubMed/NCBI
12	Gui MJ, Dashper SG, Slakeski N, Chen YY and Reynolds EC: Spheres of influence: Porphyromonas gingivalis outer membrane vesicles. Mol Oral Microbiol. 31:365–378. 2016. View Article : Google Scholar
13	Guo Y, Nguyen KA and Potempa J: Dichotomy of gingipains action as virulence factors: From cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontol 2000. 54:15–44. 2010. View Article : Google Scholar : PubMed/NCBI
14	Grenier D, Roy S, Chandad F, Plamondon P, Yoshioka M, Nakayama K and Mayrand D: Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of porphyromonas gingivalis. Infect Immun. 71:4742–4748. 2003. View Article : Google Scholar : PubMed/NCBI
15	Lalla E, Lamster IB, Feit M, Huang L and Schmidt AM: A murine model of accelerated periodontal disease in diabetes. J Periodontal Res. 33:387–399. 1998. View Article : Google Scholar : PubMed/NCBI
16	Graves DT, Kang J, Andriankaja O, Wada K and Rossa C Jr: Animal models to study host-bacteria interactions involved in periodontitis. Front Oral Biol. 15:117–132. 2012. View Article : Google Scholar
17	Baker PJ, Evans RT and Roopenian DC: Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol. 39:1035–1040. 1994. View Article : Google Scholar : PubMed/NCBI
18	Bainbridge B, Verma RK, Eastman C, Yehia B, Rivera M, Moffatt C, Bhattacharyya I, Lamont RJ and Kesavalu L: Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar bone resorption in rats. Infect Immun. 78:4560–4569. 2010. View Article : Google Scholar : PubMed/NCBI
19	Baker PJ, Dixon M, Evans RT and Roopenian DC: Heterogeneity of Porphyromonas gingivalis strains in the induction of alveolar bone loss in mice. Oral Microbiol Immunol. 15:27–32. 2000. View Article : Google Scholar
20	Dumitrescu AL, Abd-El-Aleem S, Morales-Aza B and Donaldson LF: A model of periodontitis in the rat: Effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation. J Clin Periodontol. 31:596–603. 2004. View Article : Google Scholar : PubMed/NCBI
21	Nishida E, Hara Y, Kaneko T, Ikeda Y, Ukai T and Kato I: Bone resorption and local interleukin-1alpha and interleukin-1beta synthesis induced by Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res. 36:1–8. 2001. View Article : Google Scholar : PubMed/NCBI
22	Marchesan J, Girnary MS, Jing L, Miao MZ, Zhang S, Sun L, Morelli T, Schoenfisch MH, Inohara N, Offenbacher S and Jiao Y: An experimental murine model to study periodontitis. Nat Protoc. 13:2247–2267. 2018. View Article : Google Scholar : PubMed/NCBI
23	Kimura S, Nagai A, Onitsuka T, Koga T, Fujiwara T, Kaya H and Hamada S: Induction of experimental periodontitis in mice with Porphyromonas gingivalis-adhered ligatures. J Periodontol. 71:1167–1173. 2000. View Article : Google Scholar : PubMed/NCBI
24	Suh JS, Lee SH, Fouladian Z, Lee JY, Kim T, Kang MK, Lusis AJ, Boström KI, Kim RH and Park NH: Rosuvastatin prevents the exacerbation of atherosclerosis in ligature-induced periodontal disease mouse model. Sci Rep. 10:63832020. View Article : Google Scholar : PubMed/NCBI
25	Belanger M, Rodrigues P and Progulske-Fox A: Genetic manipulation of porphyromonas gingivalis. Curr Protoc Microbiol. Chapter 13: Unit13C.2. 2007. View Article : Google Scholar
26	Velsko IM, Chukkapalli SS, Rivera MF, Lee JY, Chen H, Zheng D, Bhattacharyya I, Gangula PR, Lucas AR and Kesavalu L: Active invasion of oral and aortic tissues by Porphyromonas gingivalis in mice causally links periodontitis and atherosclerosis. PLoS One. 9:e978112014. View Article : Google Scholar : PubMed/NCBI
27	Siegel SD, Amer BR, Wu C, Sawaya MR, Gosschalk JE, Clubb RT and Ton-That H: Structure and mechanism of LcpA, a phosphotransferase that mediates glycosylation of a gram-positive bacterial cell wall-anchored protein. mBio. 10:e01580–01518. 2019.PubMed/NCBI
28	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
29	Hayashi C, Gudino CV, Gibson FC III and Genco CA: Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol. 25:305–316. 2010. View Article : Google Scholar : PubMed/NCBI
30	Gibson FC III, Hong C, Chou HH, Yumoto H, Chen J, Lien E, Wong J and Genco CA: Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation. 109:2801–2806. 2004. View Article : Google Scholar : PubMed/NCBI
31	Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S, Lu Y, Papapanou PN and Schmidt AM: Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 23:1405–1411. 2003. View Article : Google Scholar : PubMed/NCBI
32	Harrington WN, Nolan J, Nedosekin DA, Smeltzer MS and Zharov VP: Real-time monitoring of bacteria clearance from blood in a murine model. Cytometry A. 97:706–712. 2020. View Article : Google Scholar
33	He Y, Shiotsu N, Uchida-Fukuhara Y, Guo J, Weng Y, Ikegame M, Wang Z, Ono K, Kamioka H, Torii Y, et al: Outer membrane vesicles derived from Porphyromonas gingivalis induced cell death with disruption of tight junctions in human lung epithelial cells. Arch Oral Biol. 118:1048412020. View Article : Google Scholar : PubMed/NCBI
34	O'Brien-Simpson NM, Pathirana RD, Walker GD and Reynolds EC: Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner. Infect Immun. 77:1246–1261. 2009. View Article : Google Scholar :
35	Nativel B, Couret D, Giraud P, Meilhac O, d'Hellencourt CL, Viranaïcken W and Silva CRD: Porphyromonas gingivalis lipopolysaccharides act exclusively through TLR4 with a resilience between mouse and human. Sci Rep. 7:157892017. View Article : Google Scholar : PubMed/NCBI
36	Maekawa T, Takahashi N, Tabeta K, Aoki Y, Miyashita H, Miyauchi S, Miyazawa H, Nakajima T and Yamazaki K: Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One. 6:e202402011. View Article : Google Scholar : PubMed/NCBI
37	Parameswaran N and Patial S: Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 20:87–103. 2010. View Article : Google Scholar
38	Yunna C, Mengru H, Lei W and Weidong C: Macrophage M1/M2 polarization. Eur J Pharmacol. 877:1730902020. View Article : Google Scholar : PubMed/NCBI
39	Rajakaruna GA, Negi M, Uchida K, Sekine M, Furukawa A, Ito T, Kobayashi D, Suzuki Y, Akashi T, Umeda M, et al: Localization and density of porphyromonas gingivalis and tannerella forsythia in gingival and subgingival granulation tissues affected by chronic or aggressive periodontitis. Sci Rep. 8:95072018. View Article : Google Scholar : PubMed/NCBI
40	Delbosc S, Alsac JM, Journe C, Louedec L, Castier Y, Bonnaure-Mallet M, Ruimy R, Rossignol P, Bouchard P, Michel JB and Meilhac O: Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats. PLoS One. 6:e186792011. View Article : Google Scholar : PubMed/NCBI
41	Nakano K, Nemoto H, Nomura R, Inaba H, Yoshioka H, Taniguchi K, Amano A and Ooshima T: Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol. 24:64–68. 2009. View Article : Google Scholar : PubMed/NCBI
42	Kurihara N, Inoue Y, Iwai T, Umeda M, Huang Y and Ishikawa I: Detection and localization of periodontopathic bacteria in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 28:553–558. 2004. View Article : Google Scholar : PubMed/NCBI
43	Shimoda A, Ueda K, Nishiumi S, Murata-Kamiya N, Mukai SA, Sawada SI, Azuma T, Hatakeyama M and Akiyoshi K: Exosomes as nanocarriers for systemic delivery of the helicobacter pylori virulence factor CagA. Sci Rep. 6:183462016. View Article : Google Scholar : PubMed/NCBI
44	Takeuchi H, Sasaki N, Yamaga S, Kuboniwa M, Matsusaki M and Amano A: Porphyromonas gingivalis induces penetration of lipopolysaccharide and peptidoglycan through the gingival epithelium via degradation of junctional adhesion molecule 1. PLoS Pathog. 15:e10081242019. View Article : Google Scholar : PubMed/NCBI
45	Paigen B, Morrow A, Holmes PA, Mitchell D and Williams RA: Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:231–240. 1987. View Article : Google Scholar : PubMed/NCBI
46	Johnston TP, Baker JC, Hall D, Jamal S, Palmer WK and Emeson EE: Regression of poloxamer 407-induced atherosclerotic lesions in C57BL/6 mice using atorvastatin. Atherosclerosis. 149:303–313. 2000. View Article : Google Scholar : PubMed/NCBI
47	Johnston TP, Nguyen LB, Chu WA and Shefer S: Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis. Int J Pharm. 229:75–86. 2001. View Article : Google Scholar : PubMed/NCBI
48	Kleemann R, Princen HM, Emeis JJ, Jukema JW, Fontijn RD, Horrevoets AJG, Kooistra T and Havekes LM: Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: Evidence for antiinflammatory effects of rosuvastatin. Circulation. 108:1368–1374. 2003. View Article : Google Scholar : PubMed/NCBI
49	Park KY and Heo TH: Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice. Cardiovasc Ther. 36:e124762018. View Article : Google Scholar : PubMed/NCBI
50	Potempa J, Banbula A and Travis J: Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000. 24:153–192. 2000. View Article : Google Scholar
51	Pavloff N, Pemberton PA, Potempa J, Chen WC, Pike RN, Prochazka V, Kiefer MC, Travis J and Barr PJ: Molecular cloning and characterization of Porphyromonas gingivalis lysine-specific gingipain. A new member of an emerging family of pathogenic bacterial cysteine proteinases. J Biol Chem. 272:1595–1600. 1997. View Article : Google Scholar : PubMed/NCBI
52	Pavloff N, Potempa J, Pike RN, Prochazka V, Kiefer MC, Travis J and Barr PJ: Molecular cloning and structural characterization of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J Biol Chem. 270:1007–1010. 1995. View Article : Google Scholar : PubMed/NCBI
53	Hashimoto M, Kadowaki T, Tsukuba T and Yamamoto K: Selective proteolysis of apolipoprotein B-100 by Arg-gingipain mediates atherosclerosis progression accelerated by bacterial exposure. J Biochem. 140:713–723. 2006. View Article : Google Scholar : PubMed/NCBI
54	Shepardson NE, Shankar GM and Selkoe DJ: Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol. 68:1239–1244. 2011. View Article : Google Scholar : PubMed/NCBI
55	Vaya J and Schipper HM: Oxysterols, cholesterol homeostasis, and Alzheimer disease. J Neurochem. 102:1727–1737. 2007. View Article : Google Scholar : PubMed/NCBI